Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Thyroid Cancer Incidence around the Belgian Nuclear Sites, 2000-2014.
Demoury C, De Smedt T, De Schutter H, Sonck M, Van Damme N, Bollaerts K, Molenberghs G, Van Bladel L, Van Nieuwenhuyse A. Demoury C, et al. Among authors: bollaerts k. Int J Environ Res Public Health. 2017 Aug 31;14(9):988. doi: 10.3390/ijerph14090988. Int J Environ Res Public Health. 2017. PMID: 28858225 Free PMC article.
Childhood leukaemia near nuclear sites in Belgium, 2002-2008.
Bollaerts K, Simons K, Van Bladel L, De Smedt T, Sonck M, Fierens S, Poffijn A, Geraets D, Gosselin P, Van Oyen H, Francart J, Van Nieuwenhuyse A. Bollaerts K, et al. Eur J Cancer Prev. 2018 Mar;27(2):184-191. doi: 10.1097/CEJ.0000000000000272. Eur J Cancer Prev. 2018. PMID: 27380513 Free PMC article.
ADVANCE system testing: Benefit-risk analysis of a marketed vaccine using multi-criteria decision analysis and individual-level state transition modelling.
Bollaerts K, Ledent E, de Smedt T, Weibel D, Emborg HD, Danieli G, Duarte-Salles T, Huerta-Alvarez C, Martín-Merino E, Picelli G, Tramontan L, Sturkenboom M, Bauchau V. Bollaerts K, et al. Vaccine. 2020 Dec 22;38 Suppl 2:B65-B75. doi: 10.1016/j.vaccine.2019.09.034. Epub 2019 Oct 31. Vaccine. 2020. PMID: 31677947 Free article.
Methodology for computing the burden of disease of adverse events following immunization.
McDonald SA, Nijsten D, Bollaerts K, Bauwens J, Praet N, van der Sande M, Bauchau V, de Smedt T, Sturkenboom M, Hahné S. McDonald SA, et al. Among authors: bollaerts k. Pharmacoepidemiol Drug Saf. 2018 Jul;27(7):724-730. doi: 10.1002/pds.4419. Epub 2018 Mar 24. Pharmacoepidemiol Drug Saf. 2018. PMID: 29575242 Free PMC article.
ADVANCE: Towards near real-time monitoring of vaccination coverage, benefits and risks using European electronic health record databases.
Bollaerts K, de Smedt T, McGee C, Emborg HD, Villa M, Alexandridou M, Duarte-Salles T, Gini R, Bartolini C, de Lusignan S, Tin Tin Htar M, Titievsky L, Sturkenboom M, Bauchau V. Bollaerts K, et al. Vaccine. 2020 Dec 22;38 Suppl 2:B76-B83. doi: 10.1016/j.vaccine.2019.08.012. Epub 2019 Oct 31. Vaccine. 2020. PMID: 31677951 Free article.
52 results